13G Filing: Biotechnology Value Fund LP and Regulus Therapeutics Inc. (RGLS)
You can access the original SEC filing by clicking here.
Hedge Fund - Biotechnology Value Fund / BVF Inc
News, Interviews, and Investor Letters
- First
- << Previous
- 21 - 27
13G Filing: Biotechnology Value Fund LP and Blueprint Medicines Corp (BPMC)
You can access the original SEC filing by clicking here.
13G Filing: Biotechnology Value Fund LP and Oncomed Pharmaceuticals Inc (OMED)
You can access the original SEC filing by clicking here.
Tobira Therapeutics Inc. (TBRA): BVF Slashes Its Stake to 2.1% Following Merger Announcement
Mark Lampert's Biotechnology Value Fund LP recently filed a 13G with the US SEC to report lowering its stake in Tobira Therapeutics Inc.
Anthera Pharmaceuticals Inc (ANTH): Biotechnology Value Fund Reports 9.99% Stake
Mark Lampert's Biotechnology Value Fund recently filed a Form 13G with the SEC, in which it reported acquiring 4.58 million shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH), which amass 9.99% of the...
Cytokinetics Inc (CYTK): Mark Lampert's Biotechnology Value Fund Loads Up On More Shares
Mark Lampert's Biotechnology Value Fund has filed a Form 13G on Cytokinetics, Inc. (NASDAQ:CYTK), one of its top-10 holdings at the end of 2015.
One Of Mark Lampert's Small-Cap Biotech Picks Has Returned 84% This Year And It's Not Done Yet
Mark Lampert’s Biotechnology Value Fund recently filed its 13F with the U.S. Securities and Exchange Commission for the reporting period of March 31.
- First
- << Previous
- 21 - 27